FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

PERKINS BRADLEY A. 		2. Issuer Name and Ticker or Trading Symbol

VANGUARD HEALTH SYSTEMS INC [ VHS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EVP-Strategy & Innovation
(Last)          (First)          (Middle)

20 BURTON HILLS BOULEVARD, SUITE 100 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/1/2013
(Street)

NASHVILLE, TN 37215
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/1/2013     D    58668   D $21.00   0   D    
Restricted Stock Units   10/1/2013     D    94744   D $21.00   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   $2.80   10/1/2013     J         250252      (1)   (1) Common Stock   250252   $18.20   0   D    
Employee Stock Option (Right to Buy)   $11.79   10/1/2013     J         27973      (1)   (1) Common Stock   27973   $9.21   0   D    
Employee Stock Option (Right to Buy)   $11.81   10/1/2013     J         16195      (1)   (1) Common Stock   16195   $9.19   0   D    

Explanation of Responses:
( 1)  In connection with the completion on October 1, 2013 of the previously-announced merger (the "Merger") of Vanguard Health Systems, Inc., a Delaware corporation (the "Company"), with Orange Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Tenet Healthcare Corporation ("Parent"), pursuant to the terms of the Agreement and Plan of Merger, dated as of June 24, 2013 (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, at the effective time of the Merger, the stock options were canceled in exchange for a cash payment, subject to any required tax withholdings, equal to the excess of $21.00 per share over the exercise price per share under each stock option multiplied by the number of shares subject to such stock option.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
PERKINS BRADLEY A.
20 BURTON HILLS BOULEVARD
SUITE 100
NASHVILLE, TN 37215

EVP-Strategy & Innovation

Signatures
/s/ Gary D. Willis, Attorney-in-Fact 10/3/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Vanguard Health Systems, Inc. (NYSE:VHS)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Vanguard Health Systems, Inc. Charts.
Vanguard Health Systems, Inc. (NYSE:VHS)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Vanguard Health Systems, Inc. Charts.